De Luca Leonardo, Marini Marco, Gonzini Lucio, Boccanelli Alessandro, Casella Gianni, Chiarella Francesco, De Servi Stefano, Di Chiara Antonio, Di Pasquale Giuseppe, Olivari Zoran, Caretta Giorgio, Lenatti Laura, Gulizia Michele Massimo, Savonitto Stefano
Division of Cardiology, San Giovanni Evangelista Hospital, Tivoli (Rome), Italy.
Department of Cardiovascular Sciences, Ospedali Riuniti, Ancona, Italy.
J Am Heart Assoc. 2016 Nov 23;5(12):e004202. doi: 10.1161/JAHA.116.004202.
Age- and sex-specific differences exist in the treatment and outcome of ST-elevation myocardial infarction (STEMI). We sought to describe age- and sex-matched contemporary trends of in-hospital management and outcome of patients with STEMI.
We analyzed data from 5 Italian nationwide prospective registries, conducted between 2001 and 2014, including consecutive patients with STEMI. All the analyses were age- and sex-matched, considering 4 age classes: <55, 55 to 64, 65 to 74, and ≥75 years. A total of 13 235 patients were classified as having STEMI (72.1% men and 27.9% women). A progressive shift from thrombolysis to primary percutaneous coronary intervention occurred over time, with a concomitant increase in overall reperfusion rates (P for trend <0.0001), which was consistent across sex and age classes. The crude rates of in-hospital death were 3.2% in men and 8.4% in women (P<0.0001), with a significant increase over age classes for both sexes and a significant decrease over time for both sexes (all P for trend <0.01). On multivariable analysis, age (odds ratio 1.09, 95% CI 1.07-1.10, P<0.0001) and female sex (odds ratio 1.44, 95% CI 1.07-1.93, P=0.009) were found to be significantly associated with in-hospital mortality after adjustment for other risk factors, but no significant interaction between these 2 variables was observed (P for interaction=0.61).
Despite a nationwide shift from thrombolytic therapy to primary percutaneous coronary intervention for STEMI affecting both sexes and all ages, women continue to experience higher in-hospital mortality than men, irrespective of age.
ST段抬高型心肌梗死(STEMI)的治疗及预后存在年龄和性别差异。我们试图描述年龄和性别匹配的STEMI患者住院治疗及预后的当代趋势。
我们分析了2001年至2014年间意大利全国5个前瞻性登记处的数据,纳入连续的STEMI患者。所有分析均按年龄和性别匹配,分为4个年龄组:<55岁、55至64岁、65至74岁和≥75岁。共有13235例患者被诊断为STEMI(男性占72.1%,女性占27.9%)。随着时间推移,治疗方式逐渐从溶栓治疗转向直接经皮冠状动脉介入治疗,同时总体再灌注率上升(趋势P<0.0001),这在不同性别和年龄组中均一致。男性住院死亡率粗率为3.2%,女性为8.4%(P<0.0001),两性住院死亡率均随年龄组增加而显著上升,且随时间显著下降(所有趋势P<0.01)。多变量分析显示,校正其他危险因素后,年龄(比值比1.09,95%可信区间1.07 - 1.10,P<0.0001)和女性性别(比值比1.44,95%可信区间1.07 - 1.93,P = 0.009)与住院死亡率显著相关,但未观察到这两个变量之间存在显著交互作用(交互作用P = 0.61)。
尽管全国范围内STEMI的治疗已从溶栓治疗转向直接经皮冠状动脉介入治疗,且涉及所有年龄和性别的患者,但无论年龄如何,女性住院死亡率仍高于男性。